Compare SUVEN LIFE with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES ALKEM LABORATORIES SUVEN LIFESCIENCES/
ALKEM LABORATORIES
 
P/E (TTM) x 2.2 - - View Chart
P/BV x 0.5 7.7 6.8% View Chart
Dividend Yield % 4.4 0.6 783.2%  

Financials

 SUVEN LIFESCIENCES   ALKEM LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ALKEM LABORATORIES
Mar-16
SUVEN LIFESCIENCES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3381,589 21.3%   
Low Rs1691,232 13.8%   
Sales per share (Unadj.) Rs52.1417.5 12.5%  
Earnings per share (Unadj.) Rs6.856.3 12.1%  
Cash flow per share (Unadj.) Rs8.664.7 13.2%  
Dividends per share (Unadj.) Rs1.5012.70 11.8%  
Dividend yield (eoy) %0.60.9 65.7%  
Book value per share (Unadj.) Rs65.3292.9 22.3%  
Shares outstanding (eoy) m127.28119.57 106.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.4 144.0%   
Avg P/E ratio x37.125.1 148.1%  
P/CF ratio (eoy) x29.621.8 135.7%  
Price / Book Value ratio x3.94.8 80.7%  
Dividend payout %22.022.6 97.3%   
Avg Mkt Cap Rs m32,272168,653 19.1%   
No. of employees `0001.1NA-   
Total wages/salary Rs m6619,171 7.2%   
Avg. sales/employee Rs Th6,132.2NM-  
Avg. wages/employee Rs Th611.1NM-  
Avg. net profit/employee Rs Th803.5NM-  
INCOME DATA
Net Sales Rs m6,63549,915 13.3%  
Other income Rs m2421,645 14.7%   
Total revenues Rs m6,87751,561 13.3%   
Gross profit Rs m1,6048,482 18.9%  
Depreciation Rs m2211,006 22.0%   
Interest Rs m38671 5.6%   
Profit before tax Rs m1,5878,451 18.8%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,606 44.7%   
Profit after tax Rs m8696,731 12.9%  
Gross profit margin %24.217.0 142.3%  
Effective tax rate %45.219.0 238.0%   
Net profit margin %13.113.5 97.2%  
BALANCE SHEET DATA
Current assets Rs m6,23227,062 23.0%   
Current liabilities Rs m1,49015,324 9.7%   
Net working cap to sales %71.523.5 303.9%  
Current ratio x4.21.8 236.8%  
Inventory Days Days8667 130.0%  
Debtors Days Days8341 200.1%  
Net fixed assets Rs m4,04312,610 32.1%   
Share capital Rs m127239 53.2%   
"Free" reserves Rs m8,18334,490 23.7%   
Net worth Rs m8,31035,027 23.7%   
Long term debt Rs m181,212 1.5%   
Total assets Rs m10,38954,387 19.1%  
Interest coverage x43.113.6 316.9%   
Debt to equity ratio x00 6.2%  
Sales to assets ratio x0.60.9 69.6%   
Return on assets %8.713.6 64.2%  
Return on equity %10.519.2 54.4%  
Return on capital %19.524.9 78.5%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m5,6226,563 85.7%   
Fx outflow Rs m1,7993,012 59.7%   
Net fx Rs m3,8223,552 107.6%   
CASH FLOW
From Operations Rs m3567,259 4.9%  
From Investments Rs m-2791,864 -14.9%  
From Financial Activity Rs m-225-9,273 2.4%  
Net Cashflow Rs m-148-150 98.8%  

Share Holding

Indian Promoters % 63.4 66.9 94.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 33.1 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 0.0 -  
Shareholders   37,287 68,381 54.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 224 Points Higher; Realty and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended on a positive note.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


May 29, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - STERLING BIOTECH COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS